
Snigdha Maewall
Examiner (ID: 7, Phone: (571)272-6197 , Office: P/1612 )
| Most Active Art Unit | 1612 |
| Art Unit(s) | 1612, 1615 |
| Total Applications | 1263 |
| Issued Applications | 622 |
| Pending Applications | 158 |
| Abandoned Applications | 532 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17367413
[patent_doc_number] => 20220022465
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-01-27
[patent_title] => METHODS AND COMPOSITIONS FOR REPELLING BIRDS IN CROP PLANTS
[patent_app_type] => utility
[patent_app_number] => 17/310754
[patent_app_country] => US
[patent_app_date] => 2020-02-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 12643
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -16
[patent_words_short_claim] => 12
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17310754
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/310754 | METHODS AND COMPOSITIONS FOR REPELLING BIRDS IN CROP PLANTS | Feb 19, 2020 | Pending |
Array
(
[id] => 16252053
[patent_doc_number] => 20200261427
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-08-20
[patent_title] => TOPICAL RAPAMYCIN FORMULATIONS AND THEIR USE IN TREATING FACIAL ANGIOFIBROMAS AND OTHER SKIN DISORDERS
[patent_app_type] => utility
[patent_app_number] => 16/795052
[patent_app_country] => US
[patent_app_date] => 2020-02-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 15681
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -46
[patent_words_short_claim] => 58
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16795052
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/795052 | TOPICAL RAPAMYCIN FORMULATIONS AND THEIR USE IN TREATING FACIAL ANGIOFIBROMAS AND OTHER SKIN DISORDERS | Feb 18, 2020 | Abandoned |
Array
(
[id] => 16389419
[patent_doc_number] => 20200330360
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => MATERIAL FOR DEMINERALIZING DENTIN COLLAGEN FIBRIL, PREPARATION METHOD AND APPLICATION THEREOF
[patent_app_type] => utility
[patent_app_number] => 16/791343
[patent_app_country] => US
[patent_app_date] => 2020-02-14
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6829
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 22
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16791343
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/791343 | MATERIAL FOR DEMINERALIZING DENTIN COLLAGEN FIBRIL, PREPARATION METHOD AND APPLICATION THEREOF | Feb 13, 2020 | Abandoned |
Array
(
[id] => 17020774
[patent_doc_number] => 20210244645
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH
[patent_app_type] => utility
[patent_app_number] => 16/788568
[patent_app_country] => US
[patent_app_date] => 2020-02-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 16080
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 31
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16788568
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/788568 | ORAL CARE COMPOSITION AND DEVICES FORMED THEREWITH | Feb 11, 2020 | Abandoned |
Array
(
[id] => 17546547
[patent_doc_number] => 20220117888
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-21
[patent_title] => DRUG DELIVERY COMPOSITIONS FOR OCULAR ADMINISTRATION OF THERAPEUTICS AND METHODS OF USE THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/428616
[patent_app_country] => US
[patent_app_date] => 2020-02-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 34822
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17428616
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/428616 | DRUG DELIVERY COMPOSITIONS FOR OCULAR ADMINISTRATION OF THERAPEUTICS AND METHODS OF USE THEREOF | Feb 9, 2020 | Pending |
Array
(
[id] => 17755522
[patent_doc_number] => 11395800
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-07-26
[patent_title] => Pharmaceutical tablet and production method thereof
[patent_app_type] => utility
[patent_app_number] => 16/784692
[patent_app_country] => US
[patent_app_date] => 2020-02-07
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6225
[patent_no_of_claims] => 5
[patent_no_of_ind_claims] => 2
[patent_words_short_claim] => 94
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16784692
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/784692 | Pharmaceutical tablet and production method thereof | Feb 6, 2020 | Issued |
Array
(
[id] => 17576971
[patent_doc_number] => 20220133826
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-05-05
[patent_title] => NOVEL COMPONENT FOR CONTROLLING BIOLOGICAL FUNCTION
[patent_app_type] => utility
[patent_app_number] => 17/426788
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6335
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17426788
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/426788 | NOVEL COMPONENT FOR CONTROLLING BIOLOGICAL FUNCTION | Jan 30, 2020 | Pending |
Array
(
[id] => 17532504
[patent_doc_number] => 20220111113
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => NANOCOMPOSITE FIBERS WITH A DRAMATIC REDUCTION IN HUMAN PLASMA COAGULATION TIME
[patent_app_type] => utility
[patent_app_number] => 17/427288
[patent_app_country] => US
[patent_app_date] => 2020-01-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5590
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17427288
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/427288 | NANOCOMPOSITE FIBERS WITH A DRAMATIC REDUCTION IN HUMAN PLASMA COAGULATION TIME | Jan 30, 2020 | Pending |
Array
(
[id] => 17472478
[patent_doc_number] => 20220079982
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-03-17
[patent_title] => FORMULATION FOR TREATING TOBACCO OR PSYCHOTROPE WITHDRAWAL SYMPTOMS
[patent_app_type] => utility
[patent_app_number] => 17/423086
[patent_app_country] => US
[patent_app_date] => 2020-01-17
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5972
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17423086
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/423086 | FORMULATION FOR TREATING TOBACCO OR PSYCHOTROPE WITHDRAWAL SYMPTOMS | Jan 16, 2020 | Abandoned |
Array
(
[id] => 17454097
[patent_doc_number] => 11268952
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2022-03-08
[patent_title] => Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof
[patent_app_type] => utility
[patent_app_number] => 16/745231
[patent_app_country] => US
[patent_app_date] => 2020-01-16
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 45690
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 3
[patent_words_short_claim] => 38
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16745231
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/745231 | Flavors, flavor modifiers, tastants, taste enhancers, umami or sweet tastants, and/or enhancers and use thereof | Jan 15, 2020 | Issued |
Array
(
[id] => 17805938
[patent_doc_number] => 20220257773
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-08-18
[patent_title] => ACID TYPE SOPHOROLIPID-CONTAINING COMPOSITION WHICH IS SUPPRESSED IN BROWNING
[patent_app_type] => utility
[patent_app_number] => 17/618358
[patent_app_country] => US
[patent_app_date] => 2020-01-15
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14464
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 200
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17618358
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/618358 | ACID TYPE SOPHOROLIPID-CONTAINING COMPOSITION WHICH IS SUPPRESSED IN BROWNING | Jan 14, 2020 | Pending |
Array
(
[id] => 20371264
[patent_doc_number] => 12478679
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-11-25
[patent_title] => Pharmaceutical carrier for active substances and a pharmaceutical composition containing said carrier
[patent_app_type] => utility
[patent_app_number] => 17/420133
[patent_app_country] => US
[patent_app_date] => 2020-01-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 9
[patent_figures_cnt] => 14
[patent_no_of_words] => 8571
[patent_no_of_claims] => 10
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 98
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17420133
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/420133 | Pharmaceutical carrier for active substances and a pharmaceutical composition containing said carrier | Jan 9, 2020 | Issued |
Array
(
[id] => 16451075
[patent_doc_number] => 20200360501
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => Dimethyl Fumarate and Vaccination Regimens
[patent_app_type] => utility
[patent_app_number] => 16/729710
[patent_app_country] => US
[patent_app_date] => 2019-12-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17222
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -25
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16729710
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/729710 | Dimethyl fumarate and vaccination regimens | Dec 29, 2019 | Issued |
Array
(
[id] => 17412629
[patent_doc_number] => 20220047533
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-17
[patent_title] => External Composition
[patent_app_type] => utility
[patent_app_number] => 17/418418
[patent_app_country] => US
[patent_app_date] => 2019-12-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6242
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 14
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17418418
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/418418 | External composition | Dec 25, 2019 | Issued |
Array
(
[id] => 17398279
[patent_doc_number] => 20220040369
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-10
[patent_title] => MEDICAL ARTICLE WITH BACKING
[patent_app_type] => utility
[patent_app_number] => 17/309493
[patent_app_country] => US
[patent_app_date] => 2019-12-20
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 10827
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 113
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17309493
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/309493 | MEDICAL ARTICLE WITH BACKING | Dec 19, 2019 | Pending |
Array
(
[id] => 17014112
[patent_doc_number] => 11083731
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2021-08-10
[patent_title] => Meloxicam for the treatment of respiratory diseases in pigs
[patent_app_type] => utility
[patent_app_number] => 16/719681
[patent_app_country] => US
[patent_app_date] => 2019-12-18
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 2
[patent_no_of_words] => 3800
[patent_no_of_claims] => 8
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 71
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16719681
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/719681 | Meloxicam for the treatment of respiratory diseases in pigs | Dec 17, 2019 | Issued |
Array
(
[id] => 16389481
[patent_doc_number] => 20200330422
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-10-22
[patent_title] => Formulations for Treating and/or Preventing Disease
[patent_app_type] => utility
[patent_app_number] => 16/713685
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 37723
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -9
[patent_words_short_claim] => 57
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713685
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713685 | Formulations for Treating and/or Preventing Disease | Dec 12, 2019 | Abandoned |
Array
(
[id] => 16452428
[patent_doc_number] => 20200361854
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2020-11-19
[patent_title] => LIPID CONTAINING FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 16/713712
[patent_app_country] => US
[patent_app_date] => 2019-12-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42179
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => 0
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16713712
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/713712 | Lipid containing formulations | Dec 12, 2019 | Issued |
Array
(
[id] => 18525441
[patent_doc_number] => 11712419
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-01
[patent_title] => Liposome formulations
[patent_app_type] => utility
[patent_app_number] => 16/712261
[patent_app_country] => US
[patent_app_date] => 2019-12-12
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 7
[patent_figures_cnt] => 7
[patent_no_of_words] => 8996
[patent_no_of_claims] => 2
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 155
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 16712261
[rel_patent_id] =>[rel_patent_doc_number] =>) 16/712261 | Liposome formulations | Dec 11, 2019 | Issued |
Array
(
[id] => 19853929
[patent_doc_number] => 12256733
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-03-25
[patent_title] => Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same
[patent_app_type] => utility
[patent_app_number] => 17/286872
[patent_app_country] => US
[patent_app_date] => 2019-12-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 5737
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 457
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17286872
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/286872 | Antimicrobial mixture containing 4-(3-ethoxy-4-hydroxyphenyl)butan-2-one and an acid or silver-based compound, and cosmetic composition containing same | Dec 5, 2019 | Issued |